Abacus Wealth Partners’s Pfizer PFE Stock Holding History

Abacus Wealth Partners’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$637K	Sell	26,439 -14,145	-35%	-$370K	0.07%	118
2026 Q1	$1.14M	Buy	40,584 +6,292	+18%	+$168K	0.1%	90
2025 Q4	$854K	Buy	+34,292	New	+$865K	0.08%	121
2023 Q3	–	Sell	-5,548	Closed	-$204K	–	81
2023 Q2	$204K	Sell	5,548 -152	-3%	-$5.92K	0.06%	82
2023 Q1	$219K	Buy	5,700 +1,201	+27%	+$51.9K	0.07%	82
2022 Q4	$231K	Buy	+4,499	New	+$216K	0.08%	68
2022 Q3	–	Sell	-5,568	Closed	-$292K	–	82
2022 Q2	$292K	Hold	5,568	–	–	0.15%	56
2022 Q1	$288K	Sell	5,568 -1,189	-18%	-$61.7K	0.13%	61
2021 Q4	$399K	Sell	6,757 -1,088	-14%	-$53.9K	0.14%	61
2021 Q3	$337K	Sell	7,845 -907	-10%	-$40.2K	0.12%	66
2021 Q2	$343K	Buy	8,752 +638	+8%	+$24.8K	0.13%	60
2021 Q1	$294K	Buy	+8,114	New	+$288K	0.21%	69

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Abacus Wealth Partners's PFE Position: Q2 2026 in Review

Abacus Wealth Partners reduced its Pfizer (PFE) stake by 35% in Q2 2026, selling an estimated $370K and leaving 26,439 shares worth $637K. The position accounts for 0.07% of the portfolio, ranked #118.

Abacus Wealth Partners first reported a position in PFE in Q1 2021 and has held it in 12 quarters since. The position peaked at $1.14M in Q1 2026. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Abacus Wealth Partners held 26,439 shares of Pfizer worth $637K as of Q2 2026.
Abacus Wealth Partners sold 14,145 Pfizer shares in Q2 2026, an estimated $370K.
Pfizer made up 0.07% of Abacus Wealth Partners's portfolio in Q2 2026, its #118 holding.
Abacus Wealth Partners first reported a position in Pfizer in Q1 2021 and has held it in 12 quarters since.
Abacus Wealth Partners's Pfizer position peaked at $1.14M in Q1 2026.
2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Abacus Wealth Partners's 13F filing for Q2 2026, filed 22 Jul 2026.